The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Category

Sub-category

Conference

Novel bispecific checkpoint inhibitor MEDI5752 shows promise for advanced solid ...

Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia

Novel bispecific checkpoint inhibitor MEDI5752 shows promise for advanced solid tumours ( Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia )

Survival outcomes of unilateral RB based on pathological risk stratification-exp...

Dr Palwasha Rehman - Shaukat Khanum Memorial Cancer Hospital and Research Centre...

Survival outcomes of unilateral RB based on pathological risk stratification-experience at a tertiary care centre in Pakistan ( Dr Palwasha Rehman - Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan )

ESMO 2021 Roundup

Dr Bishal Gyawali - Queen's University, Kingston, Canada

ESMO 2021 Roundup ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )

OncoAlert and ecancer - ESMO 2021 Day 5

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer - ESMO 2021 Day 5 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

OncoAlert and ecancer weekly round up for August 16th - August 22nd, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer weekly round up for August 16th - August 22nd, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

Neo-AEGIS: Preliminary results of phase III RCT of CROSS versus perioperative ch...

Prof John Reynolds - Trinity College Dublin, Dublin, Republic of Ireland

Neo-AEGIS: Preliminary results of phase III RCT of CROSS versus perioperative chemotherapy ( Prof John Reynolds - Trinity College Dublin, Dublin, Republic of Ireland )

COSMIC-311: Cabozantinib versus placebo in patients with radioiodine-refractory ...

Dr Marcia Brose - University of Pennsylvania, Philadelphia, USA

$COSMIC-311: Cabozantinib versus placebo in patients with radioiodine-refractory differentiated thyroid cancer ( Dr Marcia Brose - University of Pennsylvania, Philadelphia, USA )$

Highlights from ASCO 2021

Dr Bishal Gyawali - Queen's University, Kingston, Canada

Highlights from ASCO 2021 ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )

OncoAlert and ecancer ASCO roundup - Day 3

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer ASCO roundup - Day 3 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

Incidence and trends of HPV-related cancers in the United States

Dr John Chan - UCSF Helen Diller Family Comprehensive Cancer Center, San Francis...

Incidence and trends of HPV-related cancers in the United States ( Dr John Chan - UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA )

Nivolumab plus ipilimumab or NIVO plus chemo versus chemo as firstline for advan...

Dr Ian Chau - The Royal Marsden, London, UK

Nivolumab plus ipilimumab or NIVO plus chemo versus chemo as firstline for advanced ESCC ( Dr Ian Chau - The Royal Marsden, London, UK )

OncoAlert and ecancer weekly roundup for April 19 - 25, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer weekly roundup for April 19 - 25, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

More from ecancer